13958-86-6

Basic information

• Product Name: 3,4-Pyridinediamine,5-methyl-(9CI)
• Synonyms: 3,4-Pyridinediamine,5-methyl-(9CI);5-Methyl-3,4-pyridinediamine;3,4-Diamino-5-methylpyridine;5-Methylpyridine-3,4-diaMine;5-Methylpyridin-3,4-diaMine
• CAS NO: 13958-86-6
• Molecular Formula: C₆H₉N₃
• Molecular Weight: 172.115
• Product Categories: PYRIDINE
• Mol File: 13958-86-6.mol

Chemical Properties

• Melting Point: 149 °C
• Boiling Point: 363.1 °C at 760 mmHg
• Flash Point: 200.9 °C
• Appearance: /
• Density: 1.190
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.648
• Storage Temp.: Keep in dark place,Inert atmosphere,Room temperature
• PKA: 9.40±0.24(Predicted)
• CAS DataBase Reference: 3,4-Pyridinediamine,5-methyl-(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 3,4-Pyridinediamine,5-methyl-(9CI)(13958-86-6)
• EPA Substance Registry System: 3,4-Pyridinediamine,5-methyl-(9CI)(13958-86-6)

Safety Data

• Hazardous Substances Data: 13958-86-6(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
3,4-Pyridinediamine,5-methyl-(9CI) is used as an intermediate in the synthesis of pharmaceuticals for its ability to contribute to the development of various drug molecules. Its unique structure allows it to be a key component in the creation of medications with specific therapeutic properties.
Used in Agrochemical Industry:
In the agrochemical sector, 3,4-Pyridinediamine,5-methyl-(9CI) serves as an intermediate in the production of agrochemicals, helping to develop compounds that can protect crops and enhance agricultural productivity.
Used as a Reagent in Organic Synthesis:
3,4-Pyridinediamine,5-methyl-(9CI) is utilized as a reagent in organic synthesis, playing a crucial role in various laboratory and industrial applications. Its chemical properties make it suitable for use in the preparation of different organic compounds.
It is essential to handle 3,4-Pyridinediamine,5-methyl-(9CI) with care and adhere to proper safety protocols during its use in any application to ensure the safety of individuals and the environment.

InChI:InChI=1/C6H9N3/c1-4-2-9-3-5(7)6(4)8/h2-3H,7H2,1H3,(H2,8,9)

Upstream product

• 18227-67-3 4-amino-3-methyl-5-nitropyridine 
• 1990-90-5 4-amino-3-methylpyridine 

Downstream Products

• 858939-32-9 2-(2,3-difluorophenyl)-7-methyl-1⁽³⁾H-imidazo[4,5-c]pyridine 

Relevant articles and documents

A model D - amino acid oxidase inhibitor and its preparation and application

The invention provides a novel D- amino acid oxidase inhibitor and a preparation and application thereof. In particular, the invention discloses derivatives of quinoxaline-2,3-diketone, which has a novel structure shown in formula A, as well as a preparation method thereof and an application as an inhibitor of D-amino acid oxidase (DAAO). The compound provided by the invention shows excellent effects of analgesia and blocking morphine analgesia tolerance, and has application value for analgesia, treating opiate drug tolerance, and anti-schizophrenia.

IMIDAZO[4,5-c]PYRIDINE COMPOUNDS AND METHODS OF ANTIVIRAL TREATMENT

The present invention relates to pharmaceutical compositions for the treatment or prevention of viral infections comprising as an active principle at least one imidazo[4,5-c]pyridine prodrug having the general Formula (A) wherein the substituents are described in the specification. The invention also relates to processes for the preparation and screening of compounds according to the invention having above mentioned general Formula and their use in the treatment or prophylaxis of viral infections.

FUSED HETEROCYCLIC COMPOUNDS, HAVING ANGIOTENSIN II ANTAGONISTIC ACTIVITY

Fused heterocyclic compounds of the formula (I): STR1 wherein R. sup.1 is an optionally substituted hydrocarbon residue which may be attached through a hetero atom; R 2 is a group capable of forming an anion or a group convertible thereinto; R 3 is an optionally substituted aromatic hydrocarbon or heterocyclic residue which contains at least one hetero atom; X is a direct bond or a spacer having an atomic length of two or less between the R 3 group and the ring W group; W is an optionally substituted aromatic hydrocarbon or heterocyclic residue which contains at least one hereto atom; a,c and d are independently selected from the group consisting of one or two optionally substituted carbon atoms and one or two optionally substituted hetero atoms; b and e are independently selected from the group consisting of one optionally substituted carbon atom and one optionally substituted nitrogen atom wherein one of b or e must be nitrogen; the dotted line is a bond to form one double bond; n is an integer of 1 or 2 and when a, which is an optionally substituted carbon atom, is taken together with R 1, the following group: STR2 may form a ring group; provided that when STR3 is a benzimidazole, thieno[3,4-d] imidazole, or thieno[2,3-d] imidazole ring, at least one of the group: STR4 and R 3 is an optionally substituted heterocyclic residue; and the pharmaceutically acceptable salts thereof, have potent angiotensin II antagonistic activity and antihypertensive activity, thus being useful as therapeutic agents for treating circulatory system diseases such as hypertensive diseases, heart diseases (e.g. hypercardia, heart failure, cardiac infarction, etc.), strokes, cerebral apoplexy, nephritis, etc.

Diaminopyridine compounds and methods of use

The present invention relates to compositions and method for inhibiting nonenzymatic cross-linking (protein aging) which contain diaminopyridines and derivates thereof. Accordingly, a composition is disclosed which comprises an agent capable of inhibiting the formation of advanced glycosylation endproducts of target proteins by reacting with the carbonyl moiety of the early glycosylation product of such target proteins formed by their initial glycosylation. The method comprises contacting the target protein with the composition. Both industrial and therapeutic applications for the invention are envisioned, as food spoilage and animal protein aging can be treated.